Central Pharmaceuticals Ltd. (DSE: CENTRALPHL)
Bangladesh
· Delayed Price · Currency is BDT 14.10
+0.70 (5.22%)
At close: Feb 3, 2025
Central Pharmaceuticals Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Cash & Equivalents | 1.25 | 1.76 | 1.19 | 1.53 | 3.08 | 4.1 | Upgrade
|
| Cash & Short-Term Investments | 1.25 | 1.76 | 1.19 | 1.53 | 3.08 | 4.1 | Upgrade
|
| Cash Growth | 5.24% | 47.79% | -22.02% | -50.27% | -24.89% | -27.93% | Upgrade
|
| Receivables | 72.51 | 73.25 | 80.4 | 79.1 | 79.05 | 56.02 | Upgrade
|
| Inventory | 21.82 | 17.79 | 21.6 | 39.7 | 61.4 | 54.06 | Upgrade
|
| Other Current Assets | 287.06 | 287.06 | 287.06 | 286.82 | 287.06 | 280.86 | Upgrade
|
| Total Current Assets | 382.63 | 379.87 | 390.24 | 407.16 | 430.58 | 395.04 | Upgrade
|
| Property, Plant & Equipment | 1,056 | 1,061 | 877.48 | 904.23 | 933.99 | 960.29 | Upgrade
|
| Other Intangible Assets | 0.09 | 0.09 | 0.1 | 0.11 | 0.13 | 0.14 | Upgrade
|
| Other Long-Term Assets | - | - | 0 | - | 0.13 | - | Upgrade
|
| Total Assets | 1,438 | 1,441 | 1,268 | 1,312 | 1,365 | 1,355 | Upgrade
|
| Accounts Payable | 7.92 | 8.46 | 5.29 | 1.5 | 0.65 | 2.04 | Upgrade
|
| Accrued Expenses | 1.04 | 0.62 | 0.81 | 0.41 | 0.68 | 0.49 | Upgrade
|
| Short-Term Debt | - | 0.3 | - | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | 36.5 | 36.5 | 36.5 | 36.5 | 27.37 | 13.88 | Upgrade
|
| Current Income Taxes Payable | 280.43 | 280.38 | 280.2 | 280.02 | 279.87 | 278.98 | Upgrade
|
| Other Current Liabilities | 6.82 | 6.82 | 6.82 | 6.82 | 6.83 | 6.85 | Upgrade
|
| Total Current Liabilities | 332.7 | 333.07 | 329.62 | 325.25 | 315.39 | 302.23 | Upgrade
|
| Long-Term Debt | 231.98 | 231.98 | 231.98 | 231.98 | 224.06 | 212.35 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 28.76 | 30.31 | 36.36 | 40.44 | 43.17 | 50.22 | Upgrade
|
| Other Long-Term Liabilities | - | - | -0 | - | - | - | Upgrade
|
| Total Liabilities | 593.44 | 595.36 | 597.95 | 597.67 | 582.62 | 564.79 | Upgrade
|
| Common Stock | 1,198 | 1,198 | 1,198 | 1,198 | 1,198 | 1,198 | Upgrade
|
| Retained Earnings | -1,086 | -1,085 | -1,043 | -999.02 | -930.64 | -922.17 | Upgrade
|
| Comprehensive Income & Other | 732.69 | 732.69 | 514.85 | 514.85 | 514.85 | 514.85 | Upgrade
|
| Shareholders' Equity | 844.84 | 845.3 | 669.88 | 713.83 | 782.21 | 790.68 | Upgrade
|
| Total Liabilities & Equity | 1,438 | 1,441 | 1,268 | 1,312 | 1,365 | 1,355 | Upgrade
|
| Total Debt | 268.47 | 268.77 | 268.47 | 268.47 | 251.43 | 226.22 | Upgrade
|
| Net Cash (Debt) | -267.23 | -267.01 | -267.28 | -266.94 | -248.36 | -222.13 | Upgrade
|
| Net Cash Per Share | -2.23 | -2.23 | -2.23 | -2.23 | -2.07 | -1.85 | Upgrade
|
| Filing Date Shares Outstanding | 119.8 | 119.8 | 119.8 | 119.8 | 119.8 | 119.8 | Upgrade
|
| Total Common Shares Outstanding | 119.8 | 119.8 | 119.8 | 119.8 | 119.8 | 119.8 | Upgrade
|
| Working Capital | 49.93 | 46.8 | 60.63 | 81.91 | 115.19 | 92.81 | Upgrade
|
| Book Value Per Share | 7.05 | 7.06 | 5.59 | 5.96 | 6.53 | 6.60 | Upgrade
|
| Tangible Book Value | 844.75 | 845.21 | 669.77 | 713.72 | 782.09 | 790.54 | Upgrade
|
| Tangible Book Value Per Share | 7.05 | 7.06 | 5.59 | 5.96 | 6.53 | 6.60 | Upgrade
|
| Land | - | 856.42 | 638.58 | - | - | - | Upgrade
|
| Buildings | - | 187.16 | 188.01 | - | - | - | Upgrade
|
| Machinery | - | 619.59 | 628.17 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.